Company profile: InVitro International
1.1 - Company Overview
Company description
- Provider of proprietary non-animal testing alternatives, with a pioneering focus on their development and application.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to InVitro International
Indigo Biosciences
HQ: United States
Website
- Description: Provider of nuclear receptor-focused products and services addressing therapeutic drug targets, including cell-based luciferase reporter assay kits for GPCR and nuclear receptors, Live Cell Multiplex assays to quantify live cells alongside nuclear receptor assays, INDIGlo luciferase detection reagent, environmental testing bioassays, and an ortholog assay portfolio for cross-species receptor activity comparison aiding selection of animal models for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Indigo Biosciences company profile →
Tagarno
HQ: Denmark
Website
- Description: Provider of digital microscopes with 60 FPS, auto focus, and ergonomic design for specialists in materials science, agriculture, food, electronics, and forensics. Portfolio includes TREND for quality control with apps and accessories, FRONT for high-power inspections, MOVE and ZAP flexarm models, and ZIP for simple magnification and high-quality image capture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tagarno company profile →
BioAffinity Technologies
HQ: United States
Website
- Description: Provider of non-invasive, early-stage cancer diagnostics, including CyPath® Lung, a sputum-based lung cancer test analyzed via flow cytometry and machine learning. Through Precision Pathology Laboratory Services, offers laboratory services and provides CyPath® Lung as a Laboratory Developed Test. Also conducts R&D to expand porphyrin-based platform technologies for targeted cancer diagnostics and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioAffinity Technologies company profile →
ProteinSimple
HQ: United States
Website
- Description: Provider of protein tools and analysis solutions that help researchers resolve protein analysis problems to reveal insights into proteins and their role in disease; part of the Protein Platforms division of Bio-Techne (NASDAQ: TECH).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProteinSimple company profile →
Ansh Labs
HQ: United States
Website
- Description: Provider of immunoassays for research and clinical diagnostics, custom immunoassay development (optimization and validation), monoclonal antibodies, and research reagents (antibodies, antigens, proteins), plus animal-specific assays for veterinary diagnostics. Focus areas include reproductive medicine, neurodegenerative disorders, and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ansh Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for InVitro International
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InVitro International
2.2 - Growth funds investing in similar companies to InVitro International
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for InVitro International
4.2 - Public trading comparable groups for InVitro International
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →